Skip to main content
Midas Edge

Kura Oncology, Inc.

For the period ended Sep 30, 2026. Filed Nov 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 10, 2026

KURA$7.570.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

INDEX TO EXHIBITS

Exhibit NumberDescriptionFiled HerewithIncorporated by Reference herein from Form or ScheduleFiling DateSEC File/Reg. Number
3.1Amended and Restated Certificate of Incorporation of the Registrant, as amended.8-K(Exhibit 3.1)6/14/2017001-37620
3.2Amended and Restated Bylaws of the Registrant.8-K(Exhibit 99.1)1/29/2026001-37620
4.1Form of Common Stock certificate.8-K(Exhibit 4.1)3/12/2015000-53058
4.2Form of Warrant Agreement issued by the Registrant on November 2, 2022 to certain Lenders.10-K (Exhibit 4.3)2/23/2023001-37620
4.3Amended and Restated Warrant Agreement, dated as of November 29, 2022, by and between the Registrant and Hercules Capital, Inc.10-K(Exhibit 4.4)2/23/2023001-37620
4.4Warrant Agreement, dated as of November 29, 2022, by and between the Registrant and Hercules Capital IV, L.P.10-K(Exhibit 4.5)2/23/2023001-37620
4.5**Registration Rights Agreement, dated January 26, 2024, by and among the Registrant and the persons party thereto.8-K(Exhibit 10.2)1/26/2024001-37620
10.1+Second Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Troy E. Wilson, Ph.D., J.D.X
10.2+Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Brian Powl.X
10.3+Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Kathleen Ford.X
10.4+Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Teresa Bair.X
10.5+Fourth Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Mollie Leoni, M.D.X
10.6+Fourth Amended and Restated Executive Employment Agreement, effective as of July 14, 2026, by and between the Registrant and Francis Burrows, Ph.D.X
10.7+Executive Employment Agreement, effective as of September 8, 2026, by and between the Registrant and Jennifer Fulk.X
10.8Consent and Waiver to Loan and Security Agreement, dated as of September 8, 2026, by and between the Registrant and Hercules Capital, Inc.X
10.9Amendment No. 1 to Sales Agreement, dated November 10, 2026, by and between the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co.X
Exhibit NumberDescriptionFiled HerewithIncorporated by Reference herein from Form or ScheduleFiling DateSEC File/Reg. Number
31.1Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1*Certifications of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.X
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X
101.SCHInline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS).X
  • Indicates management contract or compensatory plan.
  • The certification attached as Exhibit 32.1 accompanies this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

** Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.